Optium Cyber Systems, Inc. (OTC Pink: OCSY) operates as a security consulting company, in addition to the identification and acquisition of undervalued opportunities. Shares surged 23.08% through early trading on Wednesday, January 9, 2019. Over the past month, Optium has seen an average daily volume of 8,890,974 shares. However, through Wednesday morning, already 143 million shares have traded hands, equating to $228,870 in dollar volume.
Shares jumped Wednesday morning after Optium announced it has closed the acquisition of LBC Bioscience, Inc. LBC Bioscience is engaged in the development and marketing of a wide variety of organic CBD-based products, including pain relief creams and a pet product line. LBC Bioscience is also currently developing an anti-skin aging product line. Here is the full press release detailing the acquisition:
Optium Cyber Systems, Inc. Press Release:
THE WOODLANDS, TEXAS, Jan. 09, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Optium Cyber Systems, Inc. (‘Company’) (OTC:OCSY) is pleased to announce that it has closed the previously announced acquisition of LBC Bioscience Inc., an organic cannabidiol development and marketing company.
LBC Bioscience Inc. was founded by Lisa A. Nelson, a former director and officer of Optium Cyber Systems. LBC’s primary focus is the development and marketing of CBD based organic products such as hemp CBD drops, massage oils, recovery pain relief creams, anxiety and sleep solutions, supplements, edibles, and a full line of pet products. In addition, LBC is in the process of developing an anti-aging skin product line. LBC’s products can be viewed and purchased on the company’s website at www.lbcbioscienceinc.com.
About Optium Cyber Systems, Inc.
Optium Cyber Systems, Inc. (‘Optium’) is a publicly traded company having its common shares quoted on the OTC Markets under the symbol ‘OCSY’. Optium’s main focus is to identify, evaluate and then acquire undervalued opportunities with the end goal of adding shareholder value. To date, Optium has acquired a proprietary process to analyze, identify and address cyber security vulnerabilities in IT infrastructure that is scalable and transferable to any environment. In addition, it recently acquired a security and protection firm based in Houston, Texas.
About LBC Bioscience Inc.
LBC Bioscience Inc. (“LBC”) was incorporated as a C corporation under the laws of the State of Nevada in August 2015. LBC’s primary focus is developing organic products such as CBD water, drops, edibles, pet supplements, recovery balm and spray. The Company’s website is www.lbcbioscienceinc.com.
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See Optium Cyber Systems, Inc.’s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Article By: Andrew Rego